Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-4840

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4840 9)

Label for Atorvastatin Calcium 20 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package size of 90 tablets with the product number R1520090. It includes storage instructions to keep at controlled temperatures between 68-77°F and a warning to keep out of reach of children. Manufacturing details note Alkem Laboratories Ltd., Mumbai, India as the manufacturer.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph showing cumulative incidence (%) over time in years comparing Atorvastatin and Placebo. The graph indicates a lower cumulative incidence for Atorvastatin with values provided including a hazard ratio (HR=0.64) and p-value (p=0.0005). The solid line represents Atorvastatin, and the dashed line represents Placebo.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph showing the cumulative hazard percentage over time for Atorvastatin versus placebo during up to 5 years of follow-up. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The Atorvastatin group has a lower cumulative hazard than placebo, with a hazard ratio (HR) of 0.63 and p=0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph depicting the percentage of subjects experiencing a major cardiovascular event over a 5-year period for Atorvastatin doses of 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. Two lines compare the outcomes for 10 mg (dashed) and 80 mg (solid) doses.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium showing its molecular composition with associated calcium ions and water molecules. The diagram includes detailed atomic bonds and functional groups characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.